Dr Reddys Laboratories Ltd vs Innova Captab Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Dr Reddys Laboratories Ltd is ₹ 1276 as of 15 Jun 14:18 . The P/E Ratio of Dr Reddys Laboratories Ltd changed from 38.5 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Innova Captab Ltd changed from 27.2 on March 2024 to 27.9 on March 2026 . This represents a CAGR of 0.85% over 3 years The Market Cap of Dr Reddys Laboratories Ltd changed from ₹ 75095 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Innova Captab Ltd changed from ₹ 2564 crore on March 2024 to ₹ 3933 crore on March 2026 . This represents a CAGR of 15.33% over 3 years The revenue of Dr Reddys Laboratories Ltd for the Mar '26 is ₹ 8026 crore as compare to the Dec '25 revenue of ₹ 9024 crore. This represent the decline of -11.06% The revenue of Innova Captab Ltd for the Mar '26 is ₹ 449.37 crore as compare to the Dec '25 revenue of ₹ 451.95 crore. This represent the decline of -0.57% The ebitda of Dr Reddys Laboratories Ltd for the Mar '26 is ₹ 862.5 crore as compare to the Dec '25 ebitda of ₹ 2158 crore. This represent the decline of -60.04% The ebitda of Innova Captab Ltd for the Mar '26 is ₹ 66.66 crore as compare to the Dec '25 ebitda of ₹ 71.05 crore. This represent the decline of -6.18% The net profit of Dr Reddys Laboratories Ltd changed from ₹ 1392 crore to ₹ 221.3 crore over 8 quarters. This represents a CAGR of -60.13% The net profit of Innova Captab Ltd changed from ₹ 29.48 crore to ₹ 38.08 crore over 8 quarters. This represents a CAGR of 13.65% The Dividend Payout of Dr Reddys Laboratories Ltd changed from 19.03 % on March 2021 to 0 % on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Dividend Payout of Innova Captab Ltd changed from 13.68 % on March 2026 to 13.68 % on March 2026 . This represents a CAGR of 0.00% over 1 years .

About Dr Reddys Laboratories Ltd

Dr Reddy's Laboratories Limited (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives.
Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's portfolio of products and services include Active Pharmaceutical Ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations.
The company's major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.
Dr. Reddy's operates in markets across the globe.
Its major markets include - USA, India, Russia & CIS countries, and Europe. Dr Reddy's Laboratories Limited was incorporated in 1984 in Hyderabad.

About Innova Captab Ltd

Innova Captab Limited was incorporated as Harun Health Care Private Limited', dated January 3, 2005, as a Private Limited Company at Mumbai.
Thereafter, the name of the Company was changed from Harun Health Care Private Limited' to Innova Captab Private Limited', and a fresh Certificate of Incorporation dated February 2, 2010, was issued by RoC to the Company.
Subsequently, Company got converted to a Public Company on July 12, 2018, and the name was changed to Innova Captab Limited', dated July 26, 2018. The Company is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports.
Their business includes contract development and manufacturing organization (CDMO) business providing manufacturing services to Indian pharmaceutical companies, domestic branded generics business and an international branded generics business.

FAQs for the comparison of Dr Reddys Laboratories Ltd and Innova Captab Ltd

Which company has a larger market capitalization, Dr Reddys Laboratories Ltd or Innova Captab Ltd?

Market cap of Dr Reddys Laboratories Ltd is 106,328 Cr while Market cap of Innova Captab Ltd is 5,384 Cr

What are the key factors driving the stock performance of Dr Reddys Laboratories Ltd and Innova Captab Ltd?

The stock performance of Dr Reddys Laboratories Ltd and Innova Captab Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Reddys Laboratories Ltd and Innova Captab Ltd?

As of June 15, 2026, the Dr Reddys Laboratories Ltd stock price is INR ₹1273.9. On the other hand, Innova Captab Ltd stock price is INR ₹941.0.

How do dividend payouts of Dr Reddys Laboratories Ltd and Innova Captab Ltd compare?

To compare the dividend payouts of Dr Reddys Laboratories Ltd and Innova Captab Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.